Use of Blood Ketone Meters to Improve Ambulance Hyperglycaemia Care
Launched by EAST OF ENGLAND AMBULANCE SERVICE NHS TRUST · Jun 18, 2021
Trial Information
Current as of May 11, 2025
Completed
Keywords
ClinConnect Summary
Diabetic ketoacidosis (DKA) is a potentially life-threatening condition which requires immediate treatment. National Health Service (NHS) hospital guidelines recommend immediate fluid (saline) therapy. Delays in diagnosis and treatment are known to be associated with health complications and death.
There is an opportunity to involve ambulance crews to improve DKA identification and treatment times; however, currently ambulance staff do not have access to ketone testing, and fluids are recommended only when it is thought a patient is critically unwell.
In this KARMA2 feasibility study the ...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Aged 18 years or more
- • Attended by study clinician
- • Informed or Proxy consent to participate
- • Blood glucose level greater than 11mmol/L or unwell with history of diabetes
- • If required will be transported to partner hospital
- Exclusion Criteria:
- • Failure to meet inclusion criteria
- • Previously recruited to study
About East Of England Ambulance Service Nhs Trust
The East of England Ambulance Service NHS Trust (EEAST) is a leading public healthcare organization dedicated to delivering high-quality emergency medical services across the East of England. As a trusted provider within the National Health Service (NHS), EEAST is committed to advancing clinical care through innovative research and clinical trials. The Trust focuses on improving patient outcomes, enhancing pre-hospital care practices, and contributing to the body of evidence supporting emergency medical services. With a strong emphasis on collaboration, EEAST engages with various stakeholders, including academic institutions and healthcare partners, to foster a culture of research and development in the field of emergency medicine.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Melbourn, Cambs, United Kingdom
Patients applied
Trial Officials
Tom Davis
Study Director
East of England Ambulance Service NHS Trust
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials